Target intelligence / Profile preview

Pro-fibrotic Factor Expression

Molecular classification
Cytokine, Growth Factor, Extracellular Matrix Protein, Enzyme, Non-coding RNA
01

Overview

Pro-fibrotic factor expression refers to the increased production of molecules that promote fibrosis, a pathological process characterized by excessive deposition of extracellular matrix components. Key pro-fibrotic factors include TGF-β, CTGF, PAI-1, collagens, fibronectin, and P4HA3. These factors activate signaling pathways that lead to fibroblast proliferation, myofibroblast transdifferentiation, and enhanced ECM protein synthesis, resulting in tissue scarring and organ dysfunction. Targeting pro-fibrotic factor expression, particularly TGF-β signaling, is a major therapeutic strategy for treating fibrosing diseases.

Other names
Upregulation of pro-fibrotic factorsIncreased pro-fibrotic factor production
02

Mechanism of action

Inhibition or modulation of TGF-β signaling and downstream pro-fibrotic pathways.

03

Biological functions

Fibroblast activationMyofibroblast differentiationExtracellular matrix depositionCell proliferationAutocrine/paracrine signaling
04

Disease associations

Idiopathic pulmonary fibrosisLiver cirrhosisHeart failureKidney diseaseMuscular dystrophiesFibrosis
05

Safety considerations

Off-target effects of TGF-β inhibitorsPotential for immune suppressionDysregulation of ECM homeostasisReversibility of fibrosis
06

Interacting drugs

TGF-β inhibitors

2 more in the full profile.

07

Biomarkers

TGF-β levelsCTGF/CCN2 levelsCollagen levelsFibronectin levelsα-smooth muscle actin expressionP4HA3 expressionPAI-1 levelsmiR-29 family microRNA levels

Beyond the preview

Go deeper on Pro-fibrotic Factor Expression.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pro-fibrotic Factor Expression.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call